Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted PEGylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance.

about

Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted PEGylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance.

Item

http://www.wikidata.org/entity/Q55710454

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Codelivery of doxorubicin and ...... osarcoma multidrug resistance.

@en

Codelivery of doxorubicin and ...... osarcoma multidrug resistance.

@nl

type

Item

label

Codelivery of doxorubicin and ...... osarcoma multidrug resistance.

@en

Codelivery of doxorubicin and ...... osarcoma multidrug resistance.

@nl

prefLabel

Codelivery of doxorubicin and ...... osarcoma multidrug resistance.

@en

Codelivery of doxorubicin and ...... osarcoma multidrug resistance.

@nl

P1476

Codelivery of doxorubicin and ...... eosarcoma multidrug resistance

@en

P2093

Fateme Haghiralsadat

http://www.w3.org/2001/XMLSchema#string

Ghasem Amoabediny

http://www.w3.org/2001/XMLSchema#string

Marco N Helder

http://www.w3.org/2001/XMLSchema#string

Samira Naderinezhad

http://www.w3.org/2001/XMLSchema#string

Tymour Forouzanfar

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

Co-delivery of doxorubicin and SATB1 shRNA by thermosensitive magnetic cationic liposomes for gastric cancer therapy

Co-delivery of doxorubicin and Bmi1 siRNA by folate receptor targeted liposomes exhibits enhanced anti-tumor effects in vitro and in vivo.

P-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cells

A Novel Approach on Drug Delivery: Investigation of A New Nano-Formulation of Liposomal Doxorubicin and Biological Evaluation of Entrapped Doxorubicin on Various Osteosarcoma Cell Lines.

Targeting JNK-interacting-protein-1 (JIP1) sensitises osteosarcoma to doxorubicin.

Bone tumors in adolescents and young adults.

Synergistic and complete reversal of the multidrug resistance of mitoxantrone hydrochloride by three-in-one multifunctional lipid-sodium glycocholate nanocarriers based on simultaneous BCRP and Bcl-2 inhibition.

Non-viral gene delivery carrier and its three-dimensional transfection system.

Co-delivery of Se nanoparticles and pooled SiRNAs for overcoming drug resistance mediated by P-glycoprotein and class III β-tubulin in drug-resistant breast cancers.

P304

3853-3866

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IJN.S150017

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Behrouz Zandieh-Doulabi

P577

2018-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30013340

http://www.w3.org/2001/XMLSchema#string

P921

multiple drug resistance

P932

6039070

http://www.w3.org/2001/XMLSchema#string